You are here

Article Text

Article menu
Download PDFPDF
Best Evidence Topic reports
BET 2. SUBCUTANEOUS HEPARIN IS AS GOOD AS LOW-MOLECULAR-WEIGHT HEPARIN IN THE ACUTE TREATMENT OF THROMBO-EMBOLIC DISEASE

http://dx.doi.org/10.1136/emj.2008.059394

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Report by Andrew Munro, Staff Specialist

    Search checked by Cain English, Emergency Registrar

    Institution: Coffs Harbour Base Hospital, New South Wales, Australia

    Three-part question

    In [patients with DVT] is [subcutaneous unfractionated heparin as efficacious as low-molecular-weight heparin] in the [prevention of thrombo-embolic sequelae]?

    Clinical scenario

    An Emergency Department registrar presented a paper at our journal club showing the efficaciousness and cost effectiveness of home treatment with unfractionated heparin (UFH) in comparison with low-molecular-weight heparin (LMWH). We decided to look at the possibility of altering our outpatient treatment guidelines for deep vein thrombosis (DVT) and low-risk pulmonary embolism as a way of lowering the cost of treatment. As part of the process this BET was …

    View Full Text